v3.25.1
Condensed Consolidated Statements of Stockholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income, net of tax
Accumulated Deficit
Balance at Dec. 31, 2023 $ 89,420 $ 57 $ 400,685 $ 33 $ (311,355)
Balance, Shares at Dec. 31, 2023   57,214,550      
Exercise of common stock options 3   3    
Exercise of common stock options, Shares   918      
Shares issued under ATM, net of issuance costs of $150 4,850 $ 1 4,849    
Shares issued under ATM, net of issuance costs, Shares   1,041,666      
Exercise of pre-funded warrants 2 $ 1 1    
Exercise of pre-funded warrants, Shares   1,255,500      
Exercise of common stock warrants 3,808 $ 2 3,806    
Exercise of common stock warrants, Shares   1,424,272      
Issuance of common stock upon RSU vesting, shares   27,869      
Unrealized loss on available-for-sale securities (8)     (8)  
Stock-based compensation 1,881   1,881    
Net Income (Loss) (22,452)       (22,452)
Balance at Mar. 31, 2024 77,504 $ 61 411,225 $ 25 (333,807)
Balance, Shares at Mar. 31, 2024   60,964,775      
Balance at Dec. 31, 2024 $ 11,594 $ 65 416,319   (404,790)
Balance, Shares at Dec. 31, 2024   65,515,440      
Exercise of common stock options, Shares 0        
Issuance of common stock upon RSU vesting   $ 1 (1)    
Issuance of common stock upon RSU vesting, shares   365,121      
Stock-based compensation $ 825   825    
Net Income (Loss) (8,547)       (8,547)
Balance at Mar. 31, 2025 $ 3,872 $ 66 $ 417,143   $ (413,337)
Balance, Shares at Mar. 31, 2025   65,880,561